The development of molecular epidemiology to elucidate cancer risk and prognosis: a historical perspective

Christine B Ambrosone; Curtis C Harris

首页> 外文期刊>International Journal of Molecular Epidemiology and Genetics >The development of molecular epidemiology to elucidate cancer risk and prognosis: a historical perspective

【24h】

The development of molecular epidemiology to elucidate cancer risk and prognosis: a historical perspective

机译：分子流行病学的发展，以阐明癌症的风险和预后：历史的观点

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Molecular epidemiology in cancer research grew from the field of chemical carcinogenesis and the use biomarkers for environmental exposures, with incorporation of principles from early pharmacogenetics. Over the years, molecular epidemiology has become extremely complex, with studies evaluating associations between cancer risk and prognosis and numerous markers of susceptibility, exposure and early effects, as well as epidemiologic factors. In this article, we review the field of molecular epidemiology from a historical perspective, commenting on current status of the field and future directions.

机译：癌症研究中的分子流行病学源于化学致癌作用领域以及将生物标志物用于环境暴露的过程，并结合了早期药物遗传学的原理。多年来，分子流行病学变得极为复杂，研究评估了癌症风险与预后之间的关联以及许多易感性，暴露和早期影响的标记以及流行病学因素。在本文中，我们从历史的角度回顾了分子流行病学领域，并对该领域的现状和未来方向进行了评论。

著录项

来源
《International Journal of Molecular Epidemiology and Genetics》 |2010年第2期|共页
作者
Christine B Ambrosone; Curtis C Harris;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类流行病学与防疫;
关键词

相似文献

外文文献
中文文献
专利

1. The development of molecular epidemiology to elucidate cancer risk and prognosis: a historical perspective [J] . Christine B Ambrosone, Curtis C Harris International Journal of Molecular Epidemiology and Genetics . 2010,第2期

机译：分子流行病学的发展，以阐明癌症的风险和预后：历史的观点
2. The development of molecular epidemiology to elucidate cancer risk and prognosis: a historical perspective [J] . Christine B Ambrosone, Curtis C Harris International Journal of Molecular Epidemiology and Genetics . 2010,第2期

机译：分子流行病学的发展，以阐明癌症的风险和预后：历史的观点
3. New developments in the epidemiology of cancer prognosis: traditional and molecular predictors of treatment response and survival. [J] . Ambrosone CB, Rebbeck TR, Morgan GJ, Cancer epidemiology, biomarkers and prevention: A publication of the American Association for Cancer Research . 2006,第11期

机译：癌症预后流行病学的新进展：治疗反应和生存率的传统和分子预测指标。
4. DEVELOPMENT OF A SYSTEMATIC METHODOLOGY BASED ON MOLECULAREPIDEMIOLOGY TO ASSESS RISK FACTORS FOR BOVINE TUBERCULOSIS: THEEXAMPLE OF BELGIUM DURING THE 1995 TO 2006 PERIOD [C] . M.-F. HUMBLET, M. GILBERT, K. WALRAVENS, Meeting of the Society for Veterinary Epidemiology and Preventive Medicine . 2010

机译：基于分子化学体学评估牛结核病危险因素的系统方法的发展：1995至2006年比利时的例子
5. The molecular epidemiology of ovarian cancer: Protein concentrations, epigenetic modification, and polymorphisms. Examples in cancer etiology, prognosis, and treatment. [D] . Beeghly, Alicia Carola. 2005

机译：卵巢癌的分子流行病学：蛋白质浓度，表观遗传修饰和多态性。癌症病因，预后和治疗方面的例子。
6. The development of molecular epidemiology to elucidate cancer risk and prognosis: a historical perspective [O] . Christine B Ambrosone, Curtis C Harris 2010

机译：分子流行病学发展以阐明癌症风险和预后的历史观点
7. New Developments in the Epidemiology of Cancer Prognosis: Traditional and Molecular Predictors of Treatment Response and Survival [O] . C. B. Ambrosone, T. R. Rebbeck, G. J. Morgan, 2006

机译：癌症预后流行病学的新发展：治疗反应与生存的传统和分子预测因子
8. Molecular Epidemiology of Breast Cancer: Establishment of an at Risk Cohort and Methods to Improve the Collection and Use of Risk Factor Data [R] . Johnson, C. C. 2000

机译：乳腺癌的分子流行病学：建立风险队列和改善风险因素数据收集和使用的方法

The development of molecular epidemiology to elucidate cancer risk and prognosis: a historical perspective

摘要

著录项

相似文献

相关主题

期刊订阅